EGFR mutations occurred more commonly in HR+ NSCLC than HR- NSCLC (102/504, 20.2% vs. 402/2752, 14.6%; p= 0.002, q = 0.007) (Table 3A, Figure 1). Here, EGFR is linked to non-small cell lung carcinoma.